QualityStocks Stock Newsletters Archives - Page 508 of 1818

TuesdayMay 25, 2010 9:10 am

Clear Channel Outdoor Holdings, Inc. (CCO) Appoints Marty Shapiro as New VP-General Sales Manager

Yesterday, Clear Channel Outdoor Holdings, Inc. announced that it has welcomed a new Vice President, General Sales Manager for its outdoor branch, Marty Shapiro. Effective immediately, Shapiro will oversee Clear Channel Outdoor's inventory throughout New York's five boroughs, Westchester County, Hudson Valley and the New Jersey Digital Outdoor Network. He will be reporting to Harry Coghlan, President and General Manager of the New York division. Commenting on his new colleague, Coghlan remarked, "We are very excited to have someone with Marty's long and diverse media sales background join the Clear Channel Outdoor team. His experience and expertise will help take…

TuesdayMay 25, 2010 9:05 am

Congress to Vote on $11 Billion Oil Tax Increase to Clean up Spills

In an effort to clean up the massive BP oil spill, Congress is set to vote on a tax increase to finance the imitative. The new bill would quadruple a tax on oil to 32 cents a barrel, raising approximately $11 billion over the next decade. This tax would be levied on oil produced in the U.S. or imported from foreign countries. Under terms of the bill, the revenue would go to a fund managed by the Coast Guard to help pay to clean up spills in waterways, including the Gulf of Mexico. There has been little public opposition to…

TuesdayMay 25, 2010 8:56 am

China Shenghuo Pharmaceutical Holdings, Inc. (KUN) Reports Higher Sales of Xuesaitong in First Quarter of 2010

China Shenghuo Pharmaceutical Holdings, Inc. reported net income of $2,355 in the first quarter of 2010 compared to a net loss of $2.9 million in the first quarter of 2009. China Shenghuo Pharmaceutical Holdings, Inc. attributed the higher net income to improved sales of Xuesaitong, the company’s main drug product. Management also cited better control of operating expenses during the quarter. Gui Hua Lan, the CEO of China Shenghuo Pharmaceutical Holdings, Inc. said, “The increases in sales and net income were primarily due to the Company's continuous efforts to promote the sales of products and the efforts to control our…

TuesdayMay 25, 2010 8:54 am

China Yongxin Pharmaceuticals Inc. (CYXN.OB) Reports Higher Revenue and Net Income for First Quarter of 2010

China Yongxin Pharmaceuticals Inc. reported net income of $2.35 million, or $0.04 per diluted share, for the first quarter of 2010. The company reported net income of $390,000 or $0.01 per diluted share, in the same quarter in 2009. Revenues also increased sharply on a year over year basis, from $9.2 million in the first quarter of 2009 to $10.7 million in the quarter just ended. China Yongxin Pharmaceuticals Inc. reported that the Retail Drug Store segment saw a 20% increase in revenue, while the Wholesale Pharmaceutical Distribution segment had a 7% increase in revenues. China Yongxin Pharmaceuticals Inc. said…

TuesdayMay 25, 2010 8:39 am

EcoBlu Products, Inc. (ECOB.OB) Video Chart for Tuesday, May 25, 2010

ECOB made a nice move yesterday. Resistance from the 200dma is right ahead, but we are looking for a push to move through it. Please click the following link: http://www.qualitystocks.net/videocharts.php?chartvid_id=404 Let us hear your thoughts below:

MondayMay 24, 2010 3:26 pm

Vasomedical Inc. (VASO.OB) Up 80% Following Mention in QualityStocks Newsletter

Vasomedical Inc. closed today's trading at $0.21 a share, up $0.6 or 40% for the day. The upsurge in price has been accompanied by an upsurge in volume as well, with today's traded shares totaling 3.8 million, which is about 18 times the normal daily volume. The company was first covered in QualityStocks Free Daily Newsletter back on April 7, 2009. At the time, the stock was trading for only $0.04 a share. Investors that bought the stock at that time have enjoyed seeing their investment grow by 425%! Vasomedical designs, manufactures, markets and supports EECP(R) external counterpulsation systems based…

MondayMay 24, 2010 12:41 pm

NanoViricides, Inc. (NNVC.OB) Files Quarterly Report with SEC

Nanoviricides Inc. is a development stage company creating special purpose nanomaterials for viral therapy. The company's novel nanoviricide class of drug candidates are designed to specifically attack enveloped virus particles and dismantle them. The company is developing drugs against a wide variety of viral diseases. The company filed its quarterly report with the Securities and Exchange Commission (SEC) on May 20, 2010. Nanoviricides reported that it had approximately $2.85 million in cash and $305,000 in prepaid expenses as of the end of the quarter – March 31, 2010. The company also reported it spent approximately $1.583 million in research and…

MondayMay 24, 2010 11:53 am

Image Metrics Inc. (IMGX.OB) Posts Solid Q2 Results, Gives Future Expectations

Image Metrics Inc., a provider of facial animation software and services for the entertainment and film industry, today posted its financial results for the second quarter ended March 31, 2010. Image Metrics posted second-quarter revenue for 2010 at $1.6 million compared to $0.2 million in the year-ago period. The company attributes the increase primarily to growth in its customer base, and the expanding pipeline of full-service facial animation work for clients largely in the video game industry. The company also executed efforts to expand its internal sales and marketing team over the past year. Revenue for the first half of…

MondayMay 24, 2010 11:51 am

Pro-Pharmaceuticals, Inc. (PRWP.OB) Announces Plans to Submit Phase III Trial Design to FDA

Pro-Pharmaceuticals Inc. engages in the discovery, development and commercialization of advanced treatment of cancer and fibrosis. The company today said it plans to submit a phase III trial design for DAVANAT to the U.S. Food and Drug Administration during the second half of this year. DAVANAT is Pro-Pharmaceutical’s lead product candidate for cancer patients. Data from the phase II trial for end-stage colorectal cancer patients demonstrated that DAVANAT used in combination with 5-FU extended median survival 46 percent longer than the best standard of care as determined by the patients’ physicians. "I believe that DAVANAT will be a game-changer in…

MondayMay 24, 2010 10:28 am

Grey Television Inc. (GTN) Announces Gains in First Quarter 2010 Advertising Revenues

Perhaps one of the largest swings attributed to the digital age can be found in television advertising. As people are offered more options for entertainment, advertising revenues have fallen. Of late, however, revenue streams have started to shift back toward innovative television companies that were wise enough to diversify their advertising base to accommodate this change. Although a risky investment to be sure, finding a media company that has worked to change their strategies toward revenue generation may quite possibly be a profitable one. Grey Television Inc., a company operating as a television broadcast concern, operates 36 television stations in…

Site Search

Company Search

Category: QualityStocks Stock Newsletters